Nanotechnology is still relatively new in orthopedic investigation, diagnosis, and therapy. Though, nanotechnology has revolutionized orthopedic therapy research and practice in the short period that it has been researched and used. Nanotechnology provides more accurate, better bone formation, and presumably safer techniques of treating the human body, at least in terms of infection rates and the necessity for reoperations. Nanotechnology improvements have cleared the path for several innovative applications in medicine (Anjum et al., 2021), biotechnology (Dutt et al., 2023), molecular biology (Ma et al., 2021; Arnold et al., 2022), as well as research on the environment (El-Sayyad et al., 2023). Nanotechnology has been used in the pharmaceutical industry (i.e., nanomedicine) with the advancement of a variety of methods for the prevention, diagnosis, and treatment of a wide range of illnesses, comprising treatment of cancer, tissue engineering (TE) scaffolds, diagnostic imaging, and immunotherapy as well as drug distribution. Due to their ability to imitate or copy organ components of normal bone, nanomaterials offer very interesting potential for the future development of orthopedic implants (Chen, 2022). Bone transplants are necessary for orthopedics to restore irreversible injury to native healthy bones. Nanoparticles (NPs) can substantially contribute to this by providing cellular structural support (for instance, nanofunctionalized scaffolding) and affecting cell migration, proliferation, and differentiation (Wen et al., 2023a; Kunrath et al., 2023).

As the population ages, variations in lifestyles (specifically those that induce and aggravate chronic ailments like cardiac and osteoarthritic disease), bioengineering technological improvements, and augmented awareness of cosmetic implants all contribute to the exponential development of the bioimplant industry. As per market investigations, the worldwide bioimplant market is anticipated to reach $115.8 billion by 2020, growing at a compound annual growth rate (CAGR) of 10.3 percent between 2014 and 2020 (Zhao R. et al., 2021). Bioimplants have emerged as a possibly revolutionary therapeutic choice for blindness, neurological disorders, orthopedic issues, heart problem, defects, and dental problems (Figure 1) (Amirtharaj Mosas et al., 2022; Davis et al., 2022). Various bioimplants, like replacement of joints, bone plates, cardiac valves, Grafts of blood vessels, grafts in the teeth, sutures, ligaments, as well as intraocular lenses, are commonly utilized to 1) repair or modify the function of damaged or deteriorating tissues, 2) modify the functioning of a physical element, 3) aid in treatment, and 4) renovate anomalies for purely cosmetic purposes (Mirzaali et al., 2022). Various engineering solutions have been documented in which conventional non-metallic/metallic substances are used to simulate the physical characteristics, chemical qualities, and tissue or organ gradient architecture (Li et al., 2023). Moreover, DNA-based implants and materials are also an attractive strategy for orthopedic applications and bone cancers (Qi et al., 2022). Though, conventional bioimplants have numerous constraints. They seldom react with tissues, are unsuited to tissue, and are not continuously tolerated by the human body (Bian et al., 2016). For instance, ceramic cranium complications are well-known. Some total ceramic hip arthroplasties have resulted in perceptible noise when the patient walks. This effect results in extremely low patient satisfaction and is a well-known reason for revision in otherwise symptom-free arthroplasty. Ceramic is also quite brittle and can fracture in vivo, particularly in a hard-on-hard environment, resulting in a calamitous joint failure with microscopic ceramic detritus (Szczęsny et al., 2022).

In recent years, nanotechnology’s impact on the graft industry has hastened. Particularly, NPs having biologically inspired features attract investigators to examine their potential for enhancing the functionality of conventional grafts. This review paper investigates the progress in orthopedic uses of biomaterial, from conventional (for instance, non-metallic and metallic) assets to NPs. Orthopedic therapy depends on largely precise diagnosis of therapeutic sites and effective implanting. Recent advancements in important orthopedic biomaterials, such as materials with pores, smart biomaterials, and 3D printed nanocomposite implants, as well as commercial issues, are addressed to provide a comprehensive overview of this swiftly broadening scientific field. This research offers the basis for the incorporation of nanotechnology-powered orthopedic implants within the human body.

Although the major focus of nanophase medication transport systems has been on curing and avoiding infections related to grafts and artificial joints, this innovative strategy has also been demonstrated to be useful in tumor detection and therapy, as it enables a more focused attack on tumor cells and might aid in bone formation when paired with anabolic medicines to minimize osteolysis of the surfaces of prosthetic joints (Mittal et al., 2022). The advancement of injectable medicines encased in nanospheres accomplished by extending the pharmacological activity of a drug is a new and promising area of research. A few of them are discussed below.

Savvidou et al. (2016) found that nanoscience-based orthopaedic oncology implants can substantially improve diagnostics, surmount resistance to medicines, decrease peripheral injury to healthy host tissue, and more proficiently transport medications to tumor cells. Nanomaterials have the capacity to transport ligands. By integrating specific ligands that bond to the different genes generated by cancer cells, primary and precise identification of primary and metastatic malignant bone tumours can be improved. Through the incorporation of contrast agents into NPs, it is feasible to boost the precision of targeted cancer imaging and to predict tumor survival, which could be extremely beneficial for clinical assessment and surgical planning. Cancer cells become more resistant by generating multidrug resistance (MDR) proteins on their surface, which serves as a pump, extracting the cancer drug from cells and reducing plasma amounts. NPs make it easier to create vehicles that can effectively transport cancer medicines into cells, as well as transporting specific genetic codes that can circumvent MDR proteins. Active and passive tumor cell targeting is enhanced by nanophasic drug carrier techniques. To determine the target tumor cell, drug-loaded NPs may be linked to polymers, for example, mannose and folic acid following endocytosis. As a result of their diminutive size (targeting passively) as well as the penetration of cancer cells, nanomaterials could also allow for increased medication concentrations within cancer cells. The formation of ancestor cells and haematological stem cells (HSC) utilizing zwitterionic hydrogels may facilitate the clinical application of HSC treatment (Bai et al., 2019).

Orthopedic grafts are frequently inserted in patients who have undergone resections for bone malignancy. Though, traditional substances are not meant to suppress the progression or reappearance of tumors. As a result, efforts are being developed to make implants that stimulate typical bone development while preventing tumor development. Selenium has been demonstrated to have comparable properties and nano-selenium implants have been found to avoid malignant osteoblast propagation whereas boosting bone formation at the graft-tissue interaction (Tran et al., 2010). In contrast to titanium (Ti) grafts that have not been treated, the selenium NPs increased calcium deposition, bone adhesion, bone formation, and alkaline phosphatase activity. Currently, nanosized magnesium alloy grafts with particle refinement have demonstrated antitumor properties. This substance decreased osteosarcoma cell survival and adhesion (Nayak et al., 2016).

The management of segmented bone defects induced by unsuccessful fixations, trauma, or arthroplasty is extremely challenging. Present methods for correcting these issues, such as substitution of metal matrices and auto/allografts have disadvantages, such as inadequate availability, infection risk, and not enough characteristic of scaffolding, which restricts the degree of integration (Wu et al., 2022). Nanostructured nanomaterials are excellent because bone cells can colonize them (Andreacchio et al., 2018). The degree of interaction between the host tissues and biomaterial determines the best bone integration scaffold. The optimal structures must be biodegradable and function as extracellular matrices upon which cells can interact, proliferate, and distinguish into normal tissues.

Nanomaterial polymers can provide structural support as well as optimal pore sizes for cell movement and activity, and functioning as a cell migration medium and activity. In addition, they can give biochemical indicators for tissue transformation through the incorporation of chemokines and growth factors, and mechanical assistance by supplying peptide sequences that attach to receptors and stimulate intracellular pathways of signaling (Habibzadeh et al., 2022). These properties of NPs make them suitable for curing significant bone deformities. Once their biological, biochemical, structural, and templating operations have been accomplished, nanoscaffolds will deteriorate, allowing more normal healing without complications related to non-disintegrable implants and biomaterials (Roddy et al., 2018).

To remedy bone abnormalities, various nanostructured substances, both synthetic and natural, have been examined. While natural nanomaterials have high biocompatibility, their mechanical features and structural support are inadequate. In comparison, artificial substances, give greater structural support but are not biocompatible. NPs that have been synthesized, such as Bellucci et al. (2016) as well as a polymeric matrix, are currently suggested as scaffolding materials for the treatment of skeletal abnormalities due to their capacity to provide increased structural strength. External growth factor therapy like bone sialoproteins (BSP) and bone morphogenic proteins (BMP) could increase the capability of these nanostructured biomaterial to achieve efficient bone integration. Two natural polymers, gelatin, and fibrin, have been employed to restore lesions of bone in non-weight-bearing locations, for example, cranial abnormalities.

Because of the more complex structure of cartilage, It is more difficult to treat cartilaginous anomalies via artificial or biological frameworks. Due to their high biocompatibility, penetration of cells, neovascularization, and recyclability, biological protein scaffolding, for example, collagen and polysaccharides scaffolds, chondroitin sulphate, agarose, HA, and chitosan are suggested for cartilage healing (Vasita and Katti, 2006). Even though it is immunogenic, Type I collagen scaffolds are the most widely used. It has been demonstrated that MSCs found in acid-treated collagen polymers generate hyaline-like cartilage in individuals with chondral deformities. Gelatin is a substitute for collagen that has been denatured and does not result in immunoreactivity or transmission of disease.

Provided that the majority of lesion cartilage is amenable to less invasive surgical procedures, the availability of injected scaffolding is crucial. Hydrogels are injectable nanoscale systems composed of polymers containing collagen or gelatin that can solidify and adhere to the contour of the fault following implantation. When equipped with chondrocytes and administered, Hydrogels have been proven to generate an ECM that resembles cartilage with a continual increase in mechanical properties due to the constant development of a glycosaminoglycan-rich matrix.

Utilizing nanofibers to make chondrogenic or osteogenic frameworks have resulted in various advantages, comprising of improved cell adhesion, movement, and propagation. The scaffolds made of nanotubes had the highest amount of type II collagen, a greater ability to absorb proteins from human blood, and a substantial increase in the amount of expression of cartilage-specific genes and proteins, for instance, collagen IX and II (D’Antimo et al., 2017) recognized cartilage and bone TE defects as one of the most significant applications of nanotechnology and interrelated investigations in orthopedics.

Soft tissues (ligaments, synovial membranes, skin, and fibrous tissues) and hard tissues (bone, cartilage, teeth, and nails), which can or could not contain mineral components, are the two major categories of biological tissues. Investigators have developed novel techniques for modeling or duplicating organs due to the scarcity of organ donors (Carvalho et al., 2018). In response to this need, bioimplants have been devised to renovate, maintain, or improve the functioning of human tissues. Although biomaterials intended for grafting applications are identical to biomolecules such as tissue and bone, they are not similar. These artificial or natural biomaterials are designed to act correctly in biological environments. In orthopedic grafts, biomaterials are utilized to heal or modify the structural integrity of fractured bone. Several key conditions must be met by each biomaterial, for instance, suitable mechanical characteristics (for instance, accurate weight and elastic modulus), excellent biostability (corrosion protection, oxidation, and hydrolysis), high bio-inertness (non-irritant and harmless), biocompatibility, in the case of bone prosthesis (integration of the osseum), and easy operative use (Figure 2) (Mitragotri and Lahann, 2009).

Sridharan et al. (2015) have presented biological biomaterials that promote cell proliferation and tissue remodeling. Huebsch and Mooney (2009) and Achterberg et al. (2014) report that significant research attempts have been undertaken throughout history to create and control biomaterial properties to accomplish uses-particular biological reactions. By modulating the rigidity of the cell-substrate, for instance, it is possible to boost muscle cell growth. In the present day, orthopedic biomaterials can be classified into 02 main classes: traditional biopolymers and nanostructured biological materials. The traditional biomaterials can be classified widely into the following groups: 1) nonmetallic constituents (such as glasses that are amorphous, polymeric materials, carbon nanocomposite, and crystalline ceramics) and 2) metal and metal alloy. This article examines conventional biomaterials and the challenges they raise in orthopedic implants application.

Frequently, alloys and metals are chosen for load-bearing and anteriorly-fixed orthopedic implants. These transplants are securely affixed to the bone, certifying minimal mobility between the graft and the recipient tissue and load-bearing capacity at the site of insertion. Only a few of these substances are recyclable, and hence able to perform long-term success in graft uses, such as magnesium (Mg) in load-bearing reusable orthopedic implants (Julmi et al., 2019), stainless steel surgical grade (typically 316 L) in nonpermanent grafts (e.g., hip nails and plate fracture) (Zlotnik et al., 2019), and Ti in bone and joint replacement (Kaur and Orthopaedic biomaterials applications require specific mechanical properties for 1) stabilizing or enhancing fracture strength, 2) realignment of fragments of bones, and 3) joint substitutions. During the 1860s revolutionary industrialization, when the metal industries were experiencing growth, metallic nanomaterials were first utilized (Lausmaa et al., 1990). Metallic substances play a key role in biomedical graft engineering because of their homogenous qualities (such as a high degree of toughness, resilience, and tensile strength), manufacturing simplicity, and adequate biocompatibility, which are all looked-for graft lifespan (Kaur et al., 2017; Jenko et al., 2018; Dogra et al., 2019). Ti and its Ti6Al4V alloy are widely used in bioimplants constituents because of their fatigue performance, resistance to corrosion, excellent biocompatibility, lower cobalt level, and light weight. The zwitterionic metal-chelating polymers have improved biological distribution, higher radioactivity in the blood, reduced absorption by typical tissues, and enhanced tumor absorption. Making use of the HER2 extracellular domain, the resonance of surface plasmons experiments revealed that MCP immune conjugates were shown to have high antigen binding capabilities, with the dissociation constant in the sub-nM range (Liu et al., 2015). Utilizing a fluorescein neutravidin/isothiocyanate receptor as an intermediary, conjugation to biotinylated beads was made possible by a biotin end group. To demonstrate the behavior of the material, high-resolution image mass cytometry investigations based on 115 whereas recognition was conducted. The results suggest that [In(cb-te2pa)]+ complex-based polymers may be used in the future for mass cytometry of bio-implant (Grenier et al., 2020).

The development of an oxide coating on metal surfaces allows excellent corrosion resistance. According to Kurella and Dahotre (2005), the stability of the oxide coating on bioimplants is a major concern because it can change as a consequence of relations between the metallic surface and living tissues. The majority of metallic components disintegrate chemically and/or electrochemically in the surroundings of the human body, which consists of an oxygenated saline solution containing a salt concentration of 0.9%, a 37°C temperature, and a pH of 7.4 (Figure 3) (Manrique-Moreno et al., 2011). This oxygenated solution of saline contains, which includes the biological environment, metallic nanomaterials that have the potential to shed electrons in the solution. In such environments, these biomaterials are susceptible to corrosion, which might result in irritation and implant loosening (Li et al., 2003; Manam et al., 2017). Metallic bioimplants may fail prematurely due to the interaction of the corrosive bio-environment’s characteristics and physiological stresses. This early failure is caused by cracking due to stress corrosion of reusable metal implants, which can lead to significant material deterioration and shorten the graft’s lifespan (Choudhary et al., 2014). 316 L stainless steel implants have been demonstrated to fail because of their poor fatigue strength and/or sensitivity to distortion due to plasticity (Reclaru et al., 2001).

Many non-metallic substances, including polymers, crystalline ceramics, amorphous glasses, carbon composites, and carbon composites, exhibit intricate structural implantation features. These materials were not extensively used because of their inherent biocompatibility or lack of mechanical properties. Denry and Kelly (2014) state that significant efforts have been made to refine them as structural transplants. Due to their improved osseointegration and rejuvenation of bones abilities, polymeric materials are chosen for 1) Porous scaffolds in tissue TE and 2) controlled drug biocompatibility and exceptional electromechanical properties (Middleton and Tipton, 2000; Farah et al., 2016). Polymers have two advantages over metallic implants: 1) they can progressively convey stress to injured regions, enabling optimum healing of tissues; and 2) they can gradually restore tissue function without the use of catalysts or enzymes. Initially, biodegradable non-reinforced polymers are superior to reinforced steel materials in terms of tension and deformation by 36% and 54%, respectively. Fibre reinforcement can enhance the tensile strength of polymer substances. It is crucial to carefully choose the packing substance that will link the transplanted equipment to the human body before implanting devices. It must be feasible for these compounds to stop waste from moving between them. According to Athanasiou et al. (1998) and Nair and Laurencin (2007), ultra-high molecular weight polyethylene (UHMWPE), poly lactic acid (PLA), polyglycolide (PGA), polyhydroxyalkanoates (PHAs), polyvinylidine fluoride (PVDF), ultra-high molecular weight polyethylene (UHMWPE), and polyether ether ketone (PEEK) are the most frequently used polymers for packing orthopedic grafts. Advanced deterioration and temperature-dependent defect under load, which is analogous to rusting in the case of implant materials made of metal, are the main problems with polymers (Sabir et al., 2009). The most frequent issue with UHMWPe is oxidative damage during shelf life, which is preventable (for example, by using certain, appropriate connecting techniques). Nevertheless, Because of the small coefficient of friction with metal, they appear more plausible as a surface for complete joint expedients (Sobieraj and Rimnac, 2009). Table 1 summarizes the application of various nanoparticles in the field of orthopedics.

Nanomaterials have been investigated for their bio-implant behaviors in the past due to their bioactive nature and programmable surface features (Sobieraj and Rimnac, 2009; Waterman et al., 2011; Xu et al., 2011). Nanomaterials may be utilized in orthopedic grafts due to their ability to reduce the proportions of essential biological bone constituents. For example, nanocomposites and nanomaterial monomers have been thoroughly investigated in bone TE to improve osteointegration, promote osteoblast activity, and treat bone-related illnesses. Nanosized materials used in implants, such as nanopillars, nanotubes, nanocubes, quantum dots, nanorods, nanoflowers, and metal-organic frameworks (Bhanjana et al., 2017a; Bhanjana et al., 2017b; Kumar et al., 2018; Nehra et al., 2019), are crucial to contemplate. Numerous investigations have been made into the advantageous surface features of nanoscale components that may uphold or allow 1) many specific protein relationships, 2) enhanced osteoblast increment, and 3) enhanced osteoblast improvement as well as mobility for more effective bone progression than conventional apparatuses (Zhang, 2004; Tran et al., 2009).

Nanobiomaterials can be used in orthopedics, according to preliminary research; however, additional improvements are necessary to achieve practical application. The aim is to generate functional bone-repairing matrices that can restore natural tissues partly while interacting in relation to their surroundings, reacting to environmental variations, and actively influencing cellular processes to speed up bone creation, shorter healing times, and a quicker recovery to function. Future investigation will almost definitely concentrate on enhancing design methods employing NPs and other manufacturing methods. It is crucial to comprehend the molecular mechanisms underpinning cell-nanobiomaterial connections. In addition, caution should be taken when proving nanomaterial biosafety and limiting their consequences. Concerns exist regarding the toxicity of NPs produced by wear and strain. At the level of the nanoscale, metals behave differently and exhibit different material characteristics than at the microscale.

Therefore, conventional implants with specific features treated using nanotechnology are preferred to transplants composed of nanoparticles. This precludes the possibility of nanomaterials disseminating and influencing tissue toxicity. Given these reservations, Regulation has been proposed as a required step. Companies are still reticent to craft nanostructured implants and artificial limbs, because of their uncertain medicinal/therapeutic advantages, probable harmfulness, and expensive price (Smith et al., 2018), which are some main concerns about the toxicity of NPs produced by the use and strain. Metals react differentially and have various material characteristics at the level of the nanoscale than they do at the microscale.

Decellularized extracellular matrix (dECM) generation is a revolutionary strategy for creating biomimetic biomaterials. Decellularization is the process of successfully removing RNA, DNA, and additional components derived from tissues or organs whereas preserving the extracellular matrix’s (ECM) original composition and structural integrity (Pati et al., 2015; Zhang et al., 2016), thereby attaining the objective of reducing rejection of allografts and xenografts’ cellular antigen-induced responses. In addition to being less immunogenic, the decellularized ECM components nevertheless include a sizeable portion of the native ECM’s active components (for instance GAGs, collagen, and growth factors), which assemble themselves into gels and can be used as injected matrices for tissue restoration and healing, availability of seed cells as well as developmental materials (Hoshiba et al., 2010; Taylor et al., 2018). It is been established that employing homologous dECM scaffolds to restore matching tissues can stimulate regeneration of tissues and healing further efficiently as compared to scaffolds produced from various sources of material (Sawkins et al., 2013). Therefore, the most efficient organic substance for chondral/bone tissue rejuvenation is without a doubt dECM made from chondral/bone tissue. Pati et al. (2014), employed a mixture of bone tissues PCL and dECM to produce bone skeletons with great mechanical strength as well as stability. Similarly Beck et al. (2016a), developed decellularized cartilage gels that were methacrylated and had elastic compressive moduli comparable to natural cartilage in particular regions (1,070–150 kPa). Furthermore, to structural and chemical resemblances with natural ECM, dECM promotes the parameters in the host like stem cell growth and differentiation (Luo et al., 2015). Luo et al. injected stem cells from a human infrapatellar adipose pad onto a scaffold made of cartilage’s extracellular matrix and discovered improved cell proliferation. Choi et al. (2021), investigated in separate research the efficacy of a bone dECM-implanted electrospun PCL-based fibrous scaffold in comparison to PCL, the outcomes demonstrated that dECM had no influence on the physical qualities of the matrices, but had a considerable impact on cell adhesion, propagation, and differentiation. Lu et al. (2021) contrasted the distinctions concerning two collagen matrix approaches (in solution and solid form, correspondingly) enhanced with porcine dECM. Even though both types of dECM facilitated MSC enrollment, propagation, and chondrogenic differentiation, the latter group performed better, demonstrating a unique distinction between the two types of scaffolds in the regional microenvironment of cells formed by the dynamic modulation of biological variables throughout time, indicating that the manufacturing methods must be optimized when developing dECM-based scaffolds. In conclusion, dECM demonstrates a distinctive bioactive natural scaffold material that may be used to construct bone and cartilage tissue. Following full vs. moderately fragmented decellularization therapy, the biological activity of the dECM generated does not significantly differ from each other (Keane et al., 2012); though, few research studies have indicated that severe decellularization therapy can reduce ECM’s biological activity. Moreover, current decellularization procedures have inevitable deleterious consequences on ECM, needing further advancement of dECM physical, biological, and structural qualities throughout future formulation (Beck et al., 2016a; Beck et al., 2016b). In addition, it is difficult to increase the dECM reproducibility volumes while simultaneously scaling up manufacturing.

The future of cartilage and bone restoration would be gene-based therapy because it focuses on the processes involved in a certain illness, addressing the underlying causes instead of focusing on the symptoms. To attain this objective, a secure and efficient distribution approach is required. Although the great transfecting effectiveness of viral carriers is utilized in most pharmacogenomic approaches, its common limitations/restrictions, including immune and cellular toxicity (Ramamoorth and Narvekar, 2015), have a significant effect on clinical translation success. Current improvements in nanomedicine have led to the advancement of diverse non-viral vectors of genes that are in various stages of clinical trials. Examples include the manufacturing of peptide-NF-B siRNA NPs by Yan et al. (2016) proven to freely enter bone tissues and remain active for >14 days, thereby boosting AMPK signaling while reducing mTORC1 and Wnt/-catenin activity hence preserving cartilage integrity. PLGA-based NPs have also been utilized in cartilage injury gene therapy. Shi et al. (2013), fruitfully transfect BMP-4 plasmids into rabbit ADSCs while using PLGA NPs Additional research revealed that this nanocomplex may efficiently stimulate chondrogenesis in vivo and in vitro in matrices implanted with it. Furthermore, a comparatively novel siRNA delivery system class, e.g., liposomal nanoparticles, is anticipated to be a potent instrument for curing bone injury via silencing precise genes (Wang et al., 2018). Liposomal NPs are capable of transfecting 100 percent of chondrocytes.

Despite the emergence of nanomaterial-based therapeutic products in orthopedic disciplines, for example, drug distribution, biosensors, and scaffolds made of tissue-engineered materials, sample amounts in relevant research are small, as well as long-term planning is inadequate. Nanotoxicity and responses to inflammation cannot be disregarded and need additional preclinical research to ensure safety, given that previous research has focused on enhancing the quality of graft-host assimilation using diverse materials. It is crucial to improve communication between doctors and lab staff to provide solutions to a variety of problems, as well as constant improvement the fit between nano-design and production procedures (for instance, expanding the manufacturing of nanomaterials well-suited with 3D printers and integrating computer-assisted design in combination with analysis of finite elements to better comprehend the connection between mechanical characteristics and scaffold structure).

Even though nanotechnology is still in its infancy, It can enhance orthopedic diagnosis, management, and research. The performance of commercial and service industries verifies the notion that nanotechnology will play a crucial role in future treatment methods. Nanotechnology with the potential to significantly lower the budget of a handful of traditional medications and with the facilitation of an abundance of new applications. Nanotechnology makes accurate methods for therapy methods, as a result of which more efficient and durable grafts, reduced infection prevention, and improved bone and tendon renewal. Massive efforts in fundamental science research are beginning to realize the potential benefits of nanomedicine, particularly in orthopedics. Though, further study is required to fully understand the safety and utility of this new technology.